Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [55]
In the citing paper
“most clinically effective antipsychotics also exhibit a myriad of other actions that contribute to both therapeutic and side-effect profiles [359,360].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [360]
In the citing paper
“This often generates beneficial therapeutic activities,102 due to additive or synergistic pharmacological effects.103”
From QSAR without borders (2020) · cites this paper as [102]
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationBurris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033175 · Cited by 922
Research works printed but not linked: 1
- Hemrick–Luecke, S. et al. Pharmacological activity of aripiprazole at presynaptic and postsynaptic dopamine receptors and in antipsychotic models. Proc. Soc. Neurosci. 894.9 (2002).
Cited by
Items 801–900 of 1,000
Metabolic changes in the brain and blood of rats following acoustic trauma, tinnitus and hyperacusis
He, J. B., Aa, J., Sun, J., Smith, P. F., Ridder, D. D., Wang, G., & Zheng, Y. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.002 · Cited by 9
Structural insight into receptor-selectivity for lurasidone
Ichikawa, O., Okazaki, K., Nakahira, H., Maruyama, M., Nagata, R., Tokuda, K., Horisawa, T., & Yamazaki, K. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.005 · Cited by 9
Homopharma: A new concept for exploring the molecular binding mechanisms and drug repurposing
Chiu, Y.-Y., Tseng, J.-H., Liu, K.-H., Lin, C.-T., Hsu, K., & Yang, J. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s9-s8 · Cited by 9
Shcherbakova, I. M. (2013) · Chemistry of Heterocyclic Compounds · doi:10.1007/s10593-013-1229-x · Cited by 9
Onogi, H., Nakagawasai, O., Sato, A., Mitazaki, S., Nakaya, K., Watanabe, K., Yaoita, F., Tan–No, K., Arai, Y., Kikuchi, T., et al. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.002 · Cited by 10
Graulich, A., Léonard, M. A., Résimont, M., Huang, X., Roth, B. L., & Liégeois, J. (2010) · Australian Journal of Chemistry · doi:10.1071/ch09353 · Cited by 9
Self-citationMossaheb, N., Spindelegger, C., Asenbaum, S., Fischer, P. Q., & Barnas, C. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802269597 · Cited by 9
Preclinical assessment of CNS drug action using eye movements in mice
Cahill, H. B., Rattner, A., & Nathans, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45557 · Cited by 10
Kopinathan, A., Scammells, P. J., Lane, J. R., & Capuano, B. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0010 · Cited by 9
von Wilmsdorff, M., Manthey, F., Bouvier, M.-L., Staehlin, O., Falkai, P., Meisenzahl‐Lechner, E., Schmitt, A., & Gebicke‐Haerter, P. J. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0872-8 · Cited by 9
Receptor systems: Will mining the receptorome yield novel targets for pharmacotherapy?
Roth, B. L. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.013 · Cited by 10
Self-citationDrug Molecules and Biology: Network and Systems Aspects
Young, M. P., Zimmer, S., & Whitmore, A. V. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00032 · Cited by 13
Wang, Z., Zhang, X., Li, W., & Yang, B. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2967-8 · Cited by 9
Barceló, M., Raviña, E., Varela, M. J., Brea, J. M., Loza, M. I., & Masaguer, C. F. (2011) · MedChemComm · doi:10.1039/c1md00202c · Cited by 8
Cavalla, D., Oerton, E., & Bender, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12283-8 · Cited by 9
der Schyf, C. J. V. (2016) · Drug Development Research · doi:10.1002/ddr.21368 · Cited by 9
Systematic Data Mining Reveals Synergistic H3R/MCHR1 Ligands
Schaller, D., Hagenow, S., Alpert, G., Naß, A., Schulz, R., Bermúdez, M., Stark, H., & Wolber, G. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00118 · Cited by 9
Li, J., Huang, J. M., Zhang, S., Yao, C., Sun, W., Liu, B., Zhou, Y., & Wu, B. (2019) · Tetrahedron Letters · doi:10.1016/j.tetlet.2019.02.032 · Cited by 8
Kharkwal, H., Kumar, B. K., Murugesan, S., Singhvi, G., Avasthi, P., Goyal, A., Jamalis, J., & Chander, S. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0257 · Cited by 8
Tamaian, R., Porozov, Y. B., & Shityakov, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2184179 · Cited by 8
Cavaleri, F., Chattopadhyay, S., Palsule, V. V., Kar, P. K., & Chatterjee, R. (2024) · Integrative Cancer Therapies · doi:10.1177/15347354231223499 · Cited by 8
In vivo veritas, the next frontier for functionally selective GPCR ligands
Beaulieu, J. (2015) · Methods · doi:10.1016/j.ymeth.2015.08.018 · Cited by 8
Preparing and Filtering Compound Databases for Virtual and Experimental Screening
Cummings, M. D., Arnoult, É., Buyck, C., Tresadern, G., Vos, A. M., & Wegner, J. K. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633326.ch2 · Cited by 8
Novel Therapies in Childhood Heart Failure: Today and Tomorrow
Penny, D. J., & Vick, G. W. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.06.003 · Cited by 8
Javelot, H. (2015) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2015.09.001 · Cited by 9
Reyes-Parada, M. I., & Iturriaga‐Vásquez, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1227317 · Cited by 8
Synthesis and Characterization of new Azecine-Derivatives as Potential Neuroleptics
Zergiebel, S., Fleck, C., Arndt, H., Enzensperger, C., & Seeling, A. (2017) · Drug Research · doi:10.1055/s-0043-108651 · Cited by 8
Adeowo, F. Y., Ejalonibu, M. A., El-Rashedy, A. A. E., Lawal, M. M., & Kumalo, H. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1826129 · Cited by 8
Artificial intelligence systems for the design of magic shotgun drugs
Moreira‐Filho, J. T., da Silva, M. F. B., Borba, J. V. V. B., Filho, A. R. G., Muratov, E. N., Andrade, C. H., Braga, R. C., & Neves, B. J. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100055 · Cited by 9
Ablordeppey, S. Y., Lyles-Eggleston, M., Bricker, B. A., Zhang, W., Zhu, X. Y., Goodman, C. B., & Roth, B. L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.057 · Cited by 8
Self-citationDrug Discovery in Psychiatric Illness: Mining for Gold
Elmer, G. I., & Kafkafi, N. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn194 · Cited by 8
Systems Pharmacology: An Overview
Birtwistle, M. R., Hansen, J., Gallo, J. M., Muppirisetty, S., Ung, P. M. U., Iyengar, R., & Schlessinger, A. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_4 · Cited by 10
Reproductive Aging: Perimenopause and Psychopathological Symptoms
Geršak, K., Geršak, Ž. M., & Turčin, A. (2018) · InTech eBooks · doi:10.5772/intechopen.74159 · Cited by 8
Appiah‐Kubi, P., Olotu, F. A., & Soliman, M. E. S. (2019) · Molecular Informatics · doi:10.1002/minf.201900044 · Cited by 8
Aderibigbe, A. O., Pandey, P., & Doerksen, R. J. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1873187 · Cited by 8
Carato, P., Graulich, A., Jensen, N., Roth, B. L., & Liégeois, J.-F. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.106 · Cited by 8
Self-citationDietary Fructose and GLUT5 Transporter Activity Contribute to Antipsychotic-Induced Weight Gain
Palavicino‐Maggio, C. B., & Kuzhikandathil, E. V. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw037 · Cited by 8
Impossible or Merely Difficult? Two Grand Challenges from a Biologist’s Perspective
Roth, B. L. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000386 · Cited by 8
Self-citationRaskind, M. A., & Wang, L. Y. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000477 · Cited by 8
Alzheimer’s: The ABCDE Paradigm
Gupta, M., & Weaver, D. F. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00195 · Cited by 8
Lupori, L., Heindorf, M., Kouvaros, S., Schilling, T., Schildkamp, A., Bischofberger, J., & Keller, G. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.27.714783 · Cited by 8
Sudar, F. P., Zekerallah, S. S., Paulzen, M., Mathiak, K., & Gaebler, A. J. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116452 · Cited by 10
Lange‐Asschenfeldt, C., Brouzou, K., & Christl, J. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.07.011 · Cited by 7
Closing the Gap Between Therapeutic Use and Mode of Action in Remedial Herbs
Olivés, J., & Mestres, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01132 · Cited by 7
Loïodice, S., D’Acquisto, F., Drinkenburg, P., Suojanen, C., Llorca, P., & Manji, H. K. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104255 · Cited by 7
Scaffold Diversity Synthesis with Branching Cascades Strategy
Kumar, K. (2014) · Wiley eBooks · doi:10.1002/9783527687503.ch27 · Cited by 7
Approaches for network based drug discovery
Jayachandran, P., Ilango, S., Paital, B., Bhanja, S., & Nirmaladevi, R. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s551 · Cited by 8
Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential
Grotsch, K., & Fokin, V. V. (2022) · ACS Central Science · doi:10.1021/acscentsci.1c01100 · Cited by 9
Wang, X., Piccolo, C. W., Cohen, B. M., & Buttner, E. A. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.879717 · Cited by 7
Ma, J., Ye, N., & Cohen, B. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.013 · Cited by 8
Miniature Short Hairpin RNA Screens to Characterize Antiproliferative Drugs
Kittanakom, S., Arnoldo, A., Brown, K. R., Wallace, I. M., Kunavisarut, T., Torti, D., Heisler, L. E., Surendra, A., Moffat, J., Giaever, G. N., et al. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.006437 · Cited by 7
Schizophrenia Pharmacology: Past, Present, and Future Targets for Intervention
Cronenwett, W. J. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160009 · Cited by 7
Méndez, P. S., Eriksson, M., & Eriksson, L. A. (2017) · ACS Omega · doi:10.1021/acsomega.7b00010 · Cited by 8
O’Neal, W., Hur, E. E., Liranso, T., & Patel, B. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0074 · Cited by 7
Pharmacological Evaluation of Drugs in Animal Models of Tinnitus
Zheng, Y., McTavish, J., & Smith, P. F. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_212 · Cited by 7
Affective Disorders: Depression and Bipolar Disorders
Blackburn, T. P., & Wasley, J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00163-2 · Cited by 8
Novel Stem Cell–Based Drug Discovery Platforms for Cardiovascular Disease
Adams, W. J., & García‐Cardeña, G. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112454741 · Cited by 7
Kishi, T., Moriwaki, M., Kitajima, T., Kawashima, K., Okochi, T., Fukuo, Y., Furukawa, O., Naitoh, H., Fujita, K., & Iwata, N. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1787-x · Cited by 7
Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators
Franco, R., Canela, E. I., Casadó, V., & Ferré, S. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003653163 · Cited by 7
Hydrogen bond dynamics and conformational flexibility in antipsychotics
Pereira, J. E. M., Eckert, J., Rudić, S., Yu, D., Mole, R. A., Tsapatsaris, N., & Bordallo, H. N. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp02456e · Cited by 7
Tutone, M., & Almerico, A. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0163-1_2 · Cited by 7
Mishra, R. K., Mishra, A., & Gupta, A. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210506185510 · Cited by 7
Onogi, H., Nakagawasai, O., Tan–No, K., Mitazaki, S., Sato, A., Nakaya, K., Niijima, F., Arai, Y., Kikuchi, T., & Tadano, T. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.005 · Cited by 9
High-Dose Olanzapine for Treatment-Resistant Schizophrenia
Roth, B. L. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0201 · Cited by 7
Self-citationPsychedelic drugs as a long-needed innovation in psychiatryPreprint
Oña, G., & Bouso, J. C. (2020) · Qeios · doi:10.32388/t3em5e · Cited by 7
A molecular mechanism mediating clozapine-enhanced sensorimotor gating
Mantas, I., Flais, I., Branzell, N., Ionescu, T. M., Kim, E., Zhang, X., Cash, D., Hengerer, B., & Svenningsson, P. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02060-z · Cited by 6
Kampasis, D., Uliassi, E., & Bolognesi, M. L. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115621 · Cited by 6
Transcription factors Lef1 and Rest stimulate recovery from depressive states
Yamamoto, H., Araki, S., Onodera, R., Go, Y., & Abe, K. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02259-0 · Cited by 7
Identifying Multiple-target Ligands via Computational Chemogenomics Approaches
Peng, S., Lin, X., Guo, Z., & Huang, N. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612801319016 · Cited by 6
Kim, M., Pandit, S., & Jee, J. (2022) · Pharmaceuticals · doi:10.3390/ph15020236 · Cited by 6
Preclinical Pharmacology and Toxicology - Contributions to the Translational Interface ☆
McGonigle, P., & Williams, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05242-9 · Cited by 6
Pr, R. (2017) · Journal of Cardiology & Cardiovascular Therapy · doi:10.19080/jocct.2017.05.555660 · Cited by 8
Mondal, P. (2020) · RSC Advances · doi:10.1039/d0ra05559j · Cited by 6
Lurasidone – pharmacodynamic and pharmacokinetic properties, clinical potential and interaction risk
Siwek, M., Krupa, A. J., & Wasik, A. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/10.33450/fpn.2020.06.002 · Cited by 9
Wang, P., Yu, Y., Liu, J., Li, B., Zhang, Y., Li, D., Xu, W., Liu, Q., & Wang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637253 · Cited by 6
Singh, B., Dhuriya, Y. K., Patro, N., Thakur, M. K., Khanna, V. K., & Patro, I. K. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102035 · Cited by 7
Żuk, J., Bartuzi, D., Silva, A., Pitucha, M., Koszła, O., Wróbel, T. M., Matosiuk, D., Castro, M., & Kaczor, A. A. (2022) · Pharmacological Reports · doi:10.1007/s43440-021-00352-x · Cited by 6
Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction
Button, A. L., Hiss, J. A., Schneider, P., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201600110 · Cited by 6
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine
Monroy‐Jaramillo, N., Martínez‐Magaña, J. J., Pérez-Aldana, B. E., Ortega‐Vázquez, A., Montalvo‐Ortiz, J. L., & López, M. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0006 · Cited by 7
Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00056-0 · Cited by 6
Functional Selectivity at Serotonin Receptors
Berg, K. A., & Clarke, W. P. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_9 · Cited by 7
Computational Methods in Multitarget Drug Discovery
Bottegoni, G., & Cavalli, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00009-x · Cited by 6
Characterizing protein domain associations by Small-molecule ligand binding
Li, Q., Cheng, T., Wang, Y., & Bryant, S. H. (2012) · journal of Proteome Science and Computational Biology · doi:10.7243/2050-2273-1-6 · Cited by 6
Structure-Activity Relationships: Theory, Uses and Limitations☆
Schetz, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05329-0 · Cited by 5
Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D
Hermosilla, M. (2024) · Journal of Health Economics · doi:10.1016/j.jhealeco.2023.102855 · Cited by 5
Advances in yeast synthetic biology for human G protein–coupled receptor biology and pharmacology
Kapolka, N. J., Taghon, G. J., & Isom, D. G. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103176 · Cited by 5
Kaishima, M., 福田, 展., Ishii, J., & Kondo, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108229 · Cited by 5
Pharmacogenetic studies on the antipsychotic treatment. Current status and perspectives.
Gesteira, A., Barros, F., Martin, A., Pérez, Cortés, A., Baiget, M., & Carracedo, Á. (2010) · Actas Españolas de Psiquiatría · Cited by 9
Micoli, A., Simone, A. D., Russo, D., Ottonello, G., Colombano, G., Ruda, G. F., Bandiera, T., Cavalli, A., & Bottegoni, G. (2016) · MedChemComm · doi:10.1039/c5md00590f · Cited by 5
Song, J., Liu, X., Zhu, J., Tootoonchi, M., Keith, J. M., Meduna, S. P., Dvorak, C. A., Eccles, W., Krawczuk, P. J., Blevitt, J. M., et al. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115607815 · Cited by 5
Yoshinaga, H., Masumoto, S., Koyama, K., Kinomura, N., Matsumoto, Y., KATO, T., Baba, S., Matsumoto, K., Horisawa, T., Oki, H., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.10.034 · Cited by 5
In vivo antidiabetic potential of standardized Gymnocarpos decandrus Forssk. Extract
El‐Hawary, S. S., Mubarek, M. M., Lotfy, R., Sleem, A. A., & Okba, M. M. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00829-9 · Cited by 5
Chakraborty, D., Das, A., & Bal, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-81261-4_9 · Cited by 7
Alisauskiene, R., Johnsen, E., Gjestad, R., Kroken, R. A., Kjelby, E., Sinkeviciute, I., Fathian, F., Joa, I., Reitan, S. K., Rettenbacher, M. A., et al. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.05.003 · Cited by 6
Wang, S., Bi, J., Li, C., & Li, B. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126707 · Cited by 5
In Silico Prediction of Drug Side Effects
Keiser, M. J. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch02 · Cited by 5
Preparation of two D2 partial agonists in C‐14 and stable isotope labeled forms
Elmore, C. S., Powell, M. E., Xiong, H., Wu, Y., Wang, L., Saunders, D., & Urbanek, R. A. (2012) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2951 · Cited by 5
Serotonin System Gene Knockouts: A Story of Mice With Implications for Man
Berger, M., & Tecott, L. H. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_19 · Cited by 7
Aboueid, L., & McCarthy, R. H. (2016) · Case Reports in Psychiatry · doi:10.1155/2016/6123913 · Cited by 5
Competitive Intelligence–based Lead Generation and Fast Follower Approaches
Jiang, Y. Y., Liu, Z., Holenz, J., & Yang, H. D. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch08 · Cited by 5
Metadata
- Authors
- Roth, B. L., Sheffler, D. J., & Kroeze, W. K.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Roth, Bryan L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-04
- Volume
- 3
- Issue
- 4
- Pages
- 353-359
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2122995608
- Cited by
- 1,155
- References
- 63
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 37 · 2023: 39 · 2022: 47 · 2021: 49 · 2020: 49 · 2019: 63 · 2018: 46 · 2017: 42 · 2016: 61 · 2015: 65 · 2014: 58 · 2013: 73 · 2012: 83
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- magic bullet, polygenic disease, mood disorders, schizophrenia, depression, bipolar disorder, central nervous system disorders, drug target selectivity, polypharmacology, antipsychotic drug development
- MeSH terms
- Humans, Schizophrenia, Antipsychotic Agents, Drugs, Investigational, Comorbidity, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.